Difficulty: Medium
Average Score: 92%
Practice
Mechanism of action of tacrolimus (FK-506) is:
Correct answer
D
Rationale
The correct answer is D) Inhibits calcineurin.
Tacrolimus, also known as FK-506, is an immunosuppressant drug commonly used in transplant patients to prevent organ rejection. It works by inhibiting calcineurin, a protein phosphatase that plays a crucial role in the activation of T-lymphocytes. By blocking calcineurin, tacrolimus prevents the production of interleukin-2, a key cytokine involved in the immune response. This ultimately leads to suppression of T-cell activation and proliferation.
Option A) Inhibits CD3 receptor is incorrect because tacrolimus does not directly inhibit the CD3 receptor, which is involved in T-cell activation.
Option B) Complement-mediated cytolysis of T lymphocytes is incorrect because tacrolimus does not target the complement system, which is a different pathway involved in immune response.
Option C) Substitution for patient's deficient immunoglobulins is incorrect because tacrolimus does not act by providing or substituting immunoglobulins in the body.
Understanding the mechanism of action of tacrolimus is essential for healthcare providers caring for patients on immunosuppressive therapy. It is crucial for nurses, pharmacists, and other healthcare professionals to be knowledgeable about how these medications work to ensure safe and effective patient care, particularly in the context of managing transplant patients.
Tacrolimus, also known as FK-506, is an immunosuppressant drug commonly used in transplant patients to prevent organ rejection. It works by inhibiting calcineurin, a protein phosphatase that plays a crucial role in the activation of T-lymphocytes. By blocking calcineurin, tacrolimus prevents the production of interleukin-2, a key cytokine involved in the immune response. This ultimately leads to suppression of T-cell activation and proliferation.
Option A) Inhibits CD3 receptor is incorrect because tacrolimus does not directly inhibit the CD3 receptor, which is involved in T-cell activation.
Option B) Complement-mediated cytolysis of T lymphocytes is incorrect because tacrolimus does not target the complement system, which is a different pathway involved in immune response.
Option C) Substitution for patient's deficient immunoglobulins is incorrect because tacrolimus does not act by providing or substituting immunoglobulins in the body.
Understanding the mechanism of action of tacrolimus is essential for healthcare providers caring for patients on immunosuppressive therapy. It is crucial for nurses, pharmacists, and other healthcare professionals to be knowledgeable about how these medications work to ensure safe and effective patient care, particularly in the context of managing transplant patients.